Sally Adams summarises a new BMJ systematic review and meta-analysis of working hours and alcohol use, which finds a link between longer working hours and risky alcohol consumption.
[read the full story...]
Helen Bould summarises a new systematic review that finds a lack of evidence for the digital treatment or prevention of eating disorders. With so many new websites and apps popping up every week, why is there no reliable evidence of positive effect?
[read the full story...]
In her first blog for the Musculoskeletal Elf, Pamela Andrews a sports therapist and a PhD candidate at Glasgow Caledonian University discusses a recent systematic reiew of meta-analyses evaluating the effectiveness of exercise for depression in adults with arthritis, fibromyalgia and other rheumatic diseases.
[read the full story...]
Maartje Luijten, Assistant Professor at the Behavioural Science Institute at Radboud University, writes her debut blog on a recent meta-analysis of deficits in behavioural inhibition in substance abuse and addiction.
[read the full story...]
Elena Marcus summarises a recent network meta-analysis published in The Lancet of the comparative efficacy and tolerability of medication for the maintenance treatment of bipolar disorder.
[read the full story...]
Andrés Fonseca appraises a recent meta-analysis of adherence to Internet CBT and face-to-face cognitive behavioural therapy for depression.
[read the full story...]
Ioana Cristea critically reviews a recent meta-analysis of Internet-based CBT for patients with chronic somatic conditions. She concludes that the review authors are offering an overly positive interpretation of their results, and that we need more high quality studies before we can recommend online cognitive behaviour therapy for this population.
[read the full story...]
Helen Bould summarises a meta-analysis of interventions for caregivers of someone with an eating disorder, which highlights a lack of high quality primary research.
[read the full story...]
Helge Hasselmann highlights a recent systematic review of anti-inflammatory drugs for depression, which concludes that NSAIDs, in particular celecoxib, decreases depressive symptoms without increased risk of adverse effects. However, the meta-analysis has a number of draw-backs, which make the study findings far from convincing.
[read the full story...]
Should all molecular research institutes looking at neurodegenerative diseases be replaced by parks, playgrounds and cycle paths? Mark Horowitz highlights a recent systematic review of modifiable risk factors associated with cognition and dementia, which suggests that from a public health perspective, there may be some sense in this idea.
[read the full story...]
